Pharma

Alkem Laboratories Ltd

ALKEM · NSE · INE540L01014
——consolidatedstandalone
Vol: 1.8L traded · 80.4% delivered
Sentiment30 · Fear
Extreme FearFearNeutralGreedExtreme Greed
Market Cap—
P/E—
P/B—
EPS—
Div Yield—
ROE18.2%
ROCE17.9%
ROE18.2%
1Y Return-9.49%
Avg. Volume0.1M
Delivery %80.4%

Price Chart

5,8905,6895,4895,2885,0887.0L14.0LOct 2025Nov 2025Jan 2026Feb 2026Mar 2026Apr 2026May 2026Jul 2026Oct 2026

About

Alkem Laboratories Ltd is a Pharma company listed on NSE.

Pharma

Technicals

Free account

Technicals

Create a free account to view momentum, moving averages, and delivery signals.

Register free

Quant

Premium

Quant metrics

Upgrade to view volatility, drawdown, factor, and risk metrics.

Upgrade

Key Ratios

Market Cap—
Current Price—
52W High / Low—
Stock P/E—
Price to Book—
EPS (TTM)—
Dividend Yield—
ROE18.2%
1Y Return-9.49%
Day Change—

Profit & Loss

ConsolidatedStandalone
Profit and loss statement
PeriodTTMFY26FY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15
Sales₹15,081 Cr₹14,712 Cr₹12,965 Cr
Expenses₹12,049 Cr₹11,706 Cr₹10,452 Cr
Operating Profit₹3,032 Cr₹3,007 Cr₹2,512 Cr
OPM %20.0%20.0%19.0%
Other Income₹412 Cr₹407 Cr₹494 Cr
Depreciation₹395 Cr₹382 Cr₹357 Cr
Interest₹178 Cr₹161 Cr₹122 Cr
Profit Before Tax₹2,872 Cr₹2,871 Cr₹2,527 Cr
Tax₹668 Cr₹520 Cr₹312 Cr
Net Profit₹2,204 Cr₹2,351 Cr₹2,215 Cr
EPS (₹)180.5192.5181.1
Dividend Payout %—28%25%
Financial history locked

Register free to see 10 more years.

Register free

Quarterly Results

Quarterly results
QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
Sales₹3,740 Cr₹3,603 Cr₹3,737 Cr₹4,001 Cr
Expenses₹2,974 Cr₹3,086 Cr₹2,909 Cr₹3,080 Cr
Operating Profit₹766 Cr₹517 Cr₹828 Cr₹921 Cr
OPM %20.0%14.0%22.0%23.0%
Depreciation₹100 Cr₹106 Cr₹95 Cr₹94 Cr
Interest₹47 Cr₹54 Cr₹42 Cr₹35 Cr
Net Profit₹521 Cr₹251 Cr₹653 Cr₹779 Cr
EPS (₹)43.519.853.264.0
Quarterly history locked

Register free to see 9 more quarters.

Register free

Balance Sheet

Balance sheet
PeriodFY26FY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15
Liabilities
Equity Capital₹24 Cr₹24 Cr₹24 Cr
Reserves₹13,796 Cr₹11,961 Cr₹10,288 Cr
Borrowings₹2,047 Cr₹1,381 Cr₹1,418 Cr
Other Liabilities₹4,991 Cr₹4,325 Cr₹3,845 Cr
Total Liabilities₹20,858 Cr₹17,691 Cr₹15,575 Cr
Assets
Fixed Assets₹3,871 Cr₹2,852 Cr₹2,873 Cr
Investments₹1,869 Cr₹1,846 Cr₹484 Cr
Receivables———
Inventory———
Cash & Equivalents———
Other Assets₹14,836 Cr₹12,445 Cr₹12,060 Cr
Total Assets₹20,858 Cr₹17,691 Cr₹15,575 Cr
Balance sheet history locked

Register free to see 10 more years.

Register free

Cash Flow

Cash flow statement
PeriodOperatingInvestingFinancingNet Cash Flow
FY26₹1,963 Cr₹-1,682 Cr₹-503 Cr₹-222 Cr
FY25₹1,913 Cr₹-1,288 Cr₹-811 Cr₹-186 Cr
FY24₹1,948 Cr₹-1,011 Cr₹-1,145 Cr₹-207 Cr
FY23
FY22
FY21
FY20
FY19
FY18
FY17
FY16
FY15
Cash flow history locked

Register free to see 10 more years.

Register free

Peer Comparison

Peer comparison
CompanyM.CapP/EROE1Y Return
3B BlackBio Dx Ltd₹1,210 Cr21.4+20.2%+17.9%
Aarey Drugs & Pharmaceuticals Ltd——+2.75%+59.84%
Aarti Drugs Ltd₹3,429 Cr18.0+13.37%+11.57%
Aarti Pharmalabs Ltd₹7,495 Cr35.2+8.51%+14.26%
Abbott India Ltd——+34.46%-7.16%

Mutual Fund Holdings

Free account

Mutual fund holdings

Create a free account to see institutional ownership snapshots.

Register free

Bulk & Block Deals

Free account

Bulk & block deals

Create a free account to view recent institutional deal activity.

Register free

Analyst Estimates

Free account

Analyst estimates

Create a free account to view analyst estimate summaries.

Register free

Latest News

2026-09-21Disclosure Under Regulation 30 Of SEBI (LODR) RegulationsBSE Filing2026-08-15Alkem Laboratories Ltd (BOM:539523) (Q1 2027) Earnings Call Highlights: Robust Revenue Growth ...GuruFocus.com2026-08-13Earnings To Watch: Alkem Laboratories Ltd (NSE:ALKEM) Q1 2027 -- GF Value Sees 26% UpsideGuruFocus.com

Documents & Filings

rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.